Informations générales (source: ClinicalTrials.gov)

NCT02666625 En recrutement IDF
Study of Iatrogenic Effects of Treatment for Childhood Cancer - Constitution of a Biological Samples Bank as Part of a Cohort of Patients (Cohort FCCSS)
Observational [Patient Registry]
  • Tumeurs
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
juillet 2013
décembre 2036
11 septembre 2026
The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
CLCC INSTITUT GUSTAVE ROUSSY Carole RUBINO En recrutement IDF 29/06/2026 07:35:04  Contacter
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CLCC INSTITUT CURIE François Doz, MD Contact (sur clinicalTrials)
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Centre Léon Bérard - 69008 - Lyon - France Amandine Bertrand, MD Contact (sur clinicalTrials)

Critères

Tous


- Patients treated for a first cancer in childhood

- Adult patients

- Signed informed consent

- Patient insured or enjoying a social security scheme

Exclusion Criteria:


- Minor patients

- Under legal protection measure patients

- Refusal of consent